1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024

Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024

  • January 2014
  • 195 pages
  • ID: 2041941
  • Format: PDF

Summary

Table of Contents

Report Details

Biotechnology for bone disorders - new study showing you trends, R&D progress, and predicted revenues
What's the future of orthobiologics and osteobiologics? Visiongain's updated report gives you predictions for those medical devices and pharmaceuticals. There you explore sales results, technologies, needs, R&D, opportunities, and revenue forecasts.
So see what's possible for those bone-repairing agents and related biotechnologies for bone diseases. You gain data and financial analysis for that industry. There find technological progress and commercial prospects for technology and medicines. Discover potential gains.
Read on to explore those treatments and see what their future market could be worth.

Forecasts and other analyses of technology for healing damaged bones

Orthobiologics constitute products using biology or biochemistry to treat musculoskeletal disorders. Sales of those drugs and other reconstructive therapies expand.
Our report covers two main segments: bone graft substitutes and biological treatments for osteoporosis. It then analyses components of those submarkets.
That new study gives you sales predictions to 2024 at overall world, submarket, product, and national level. For those therapies, you investigate where the money lies in bone repair. There find potentials, hearing how you can gain.
Besides forecasting revenues to 2024, that work shows you historical results, growth rates, and market shares. There you explore technologies, applications, and developments (R&D). You also gain 64 tables, 60 charts, and two interviews with other authorities.

Knowledge to benefit your work and save time, helping your influence

Ever had trouble finding data you need? See in our report how you could help your business research, analyses, and decisions on treatments for debilitating bone conditions. Save time too. Also benefit your authority through better understanding the present and future.
So the following sections explain what you get in our new investigation.
Forecasting of that world market and its main segments - you explore possibilities
What're the secrets of that industry's progress? Where lies potential in treating bone disorders? Discover in our work overall world revenue to 2024 for orthobiologics and biologics for osteoporosis.

Also in that report you find individual revenue predictions to 2024 for six therapeutic submarkets at world level for orthobiologics:

- Machined bone allografts
- Demineralised bone matrices
- Recombinant growth factors
- Bone substitutes
- Stem-cell therapies
- Allograft implants.
There you assess outlooks for sales growth, seeing where you can gain.
So you explore competition and rising sales for products in orthopaedics (orthopedics), and related technology for rebuilding bones, including biological drugs (biologics). You get feel for that sector and its potential.
Discover the lucrative, expanding possibilities there. You also assess top products' futures.
Predictions of leading osteopathic agents' revenues
Find sales outlooks for brands, too, seeing how they compete and succeed. Our study shows you individual revenue forecasts to 2024 for products, marketed and expected:
- INFUSE
- Prolia
- Forteo
- Preotact
- Romosozumab
- Biosimilars (follow-on biologics) for osteoporosis, grouped analysis.
There you find products and years with highest predicted sales and growth. Also you examine competitors. You see what's happening, then, understanding challenges, competition, opportunities, and sales potentials. See where you could profit.
Our work also divides its overall predictions into geographical regions.

Healthcare in leading national markets - what outlooks for those medical sales?

In developed and developing countries, opportunities for providers of bone treatments will increase from 2014 to 202

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2019 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

2019 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

  • $ 3850
  • April 2019

2019 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading SuppliersThis 154-page report provides assessments of such ...

Global Adenovirus Diagnostic Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

Global Adenovirus Diagnostic Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 2800
  • April 2019

Global Adenovirus Diagnostic Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

2019-2023 Competing in the Global Adenovirus Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2019-2023 Competing in the Global Adenovirus Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 4350
  • March 2019

2019-2023 Competing in the Global Adenovirus Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesThe ...


ref:plp2014

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on